These findings suggest that QgYp can improve liver fibrosis, and the mechanism may be related to the downregulation of the TGF-β1/Smad2/3 pathway and the inhibition of the activation and proliferation of HSCs. Here, SMAD2 is linked to Hepatic fibrosis.